Goldman Sachs
LFST icon

Goldman Sachs’s Lifestance Health LFST Stock Holding History

Goldman Sachs’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.3M Sell
2,086,443
-1,201,194
-37% -$8.36M ﹤0.01% 2817
2025
Q4 		$23.1M Sell
3,287,637
-279,716
-8% -$1.69M ﹤0.01% 2243
2025
Q3 		$19.6M Sell
3,567,353
-255,035
-7% -$1.25M ﹤0.01% 2280
2025
Q2 		$19.8M Sell
3,822,388
-615,651
-14% -$3.69M ﹤0.01% 2143
2025
Q1 		$29.6M Buy
4,438,039
+353,641
+9% +$2.69M ﹤0.01% 1663
2024
Q4 		$30.1M Buy
4,084,398
+475,676
+13% +$3.41M ﹤0.01% 1738
2024
Q3 		$25.3M Buy
3,608,722
+2,552,935
+242% +$15.3M ﹤0.01% 1831
2024
Q2 		$5.18M Buy
1,055,787
+53,893
+5% +$325K ﹤0.01% 3117
2024
Q1 		$6.18M Sell
1,001,894
-74,751
-7% -$503K ﹤0.01% 2899
2023
Q4 		$8.43M Buy
1,076,645
+755,154
+235% +$4.87M ﹤0.01% 2689
2023
Q3 		$2.21M Buy
321,491
+15,053
+5% +$122K ﹤0.01% 3694
2023
Q2 		$2.8M Buy
306,438
+160,327
+110% +$1.33M ﹤0.01% 3610
2023
Q1 		$1.09M Buy
146,111
+91,987
+170% +$510K ﹤0.01% 4328
2022
Q4 		$267K Sell
54,124
-2,703
-5% -$16.7K ﹤0.01% 5189
2022
Q3 		$376K Buy
56,827
+6,813
+14% +$47.5K ﹤0.01% 5166
2022
Q2 		$278K Buy
50,014
+9,200
+23% +$70.5K ﹤0.01% 5470
2022
Q1 		$413K Buy
40,814
+22,079
+118% +$194K ﹤0.01% 5457
2021
Q4 		$178K Sell
18,735
-421
-2% -$4.46K ﹤0.01% 5945
2021
Q3 		$278K Sell
19,156
-204,625
-91% -$3.94M ﹤0.01% 5541
2021
Q2 		$6.24M Buy
+223,781
New +$5.91M ﹤0.01% 3143

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs's LFST Position: Q1 2026 in Review

Goldman Sachs reduced its Lifestance Health (LFST) stake by 37% in Q1 2026, selling an estimated $8.36M and leaving 2,086,443 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2817.

Goldman Sachs first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $30.1M in Q4 2024. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Goldman Sachs held 2,086,443 shares of Lifestance Health worth $13.3M as of Q1 2026.
  • Goldman Sachs sold 1,201,194 Lifestance Health shares in Q1 2026, an estimated $8.36M.
  • Lifestance Health made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2817 holding.
  • Goldman Sachs first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Lifestance Health position peaked at $30.1M in Q4 2024.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.